Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MANTICORE: Preventing Cardiac Effects of Herceptin
NCT01016886Phase 2Unknown
- Sponsor
- University of Alberta
- Start
- Sep 2010
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing Perindopril, Bisoprolol and Placebo (3 arms). Primary endpoint: Left ventricular remodeling at 3.5 years. Status: unknown.
02
Drugs
perindoprilbisoprolol
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01016886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01016886.